Fig. 5
From: Prognostic, oncogenic roles, and pharmacogenomic features of AMD1 in hepatocellular carcinoma
Validation of the prognostic signature. (A-C) The OS rates of the high-risk and low-risk groups are shown for the training, testing, and external validation cohorts. (D-F) Receiver operating characteristic (ROC) curve showing the predictive accuracy of the risk score for the prognosis of the patients in the training, testing, and external validation cohorts. (G-I) ROC curves were generated to confirm the superiority of the risk score in clinical application in the training, testing, and external validation cohort. (J-L) The C-index curves for the risk score, age, gender and stage in the training, testing, and external validation cohorts